Immunological Cross-Reactions May Increase Food Allergies

This article originally appeared here.
Share this content:
Immunological Cross-Reactions May Increase Food Allergies
Immunological Cross-Reactions May Increase Food Allergies

TUESDAY, Sept. 1, 2015 (HealthDay News) -- Food allergy can be caused by immunological cross-reactions to common inhalant allergens, with diverse patterns of allergic reactions to foods observed, according to a position paper published in the September issue of Allergy.

Thomas Werfel, M.D., Ph.D., from Hannover Medical University in Germany, and colleagues discuss new food allergies that are caused by cross-reacting allergenic structures shared by inhalants and foods and seen in older children, adolescents, and adults.

The researchers note that immunoglobulin E (IgE) stimulated by a cross-reactive inhalant allergen can result in allergic reactions to different foods. After the first consumption of a food containing a cross-reactive allergen, local, mild, or severe systemic reactions may occur. In clinical practice, skin prick testing or determination of specific IgE in vitro can be used to elucidate clinically relevant sensitizations. To reach a diagnosis, component-resolved diagnosis may help, and could predict the risk of a systemic reaction. In cases of unclear history, allergy needs to be confirmed by oral challenge tests. In pollen-related food allergy, the therapeutic potential of allergen immunotherapy with inhalant allergens is unclear, with a need for more placebo-controlled studies.

"As we are facing an increasing incidence of pollen allergies, a shift in sensitization patterns and changes in nutritional habits, and the occurrence of new, so far unknown allergies due to cross-reactions are expected," the authors write.

Several authors disclosed financial ties to the medical device industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »